News

Collective Grief in the FA Community

As we remember all of those we’ve lost, it’s important to acknowledge the shockwave that is grief, which can reverberate throughout the entire community during times of loss. Most in this community have witnessed the difficulties experienced by those with...

Read More >

2022 Research Year In Review

In 2022, the Fanconi Anemia Research Fund moved full steam ahead with research priorities. Notably, we invested over $3 million into new and ongoing research efforts, with a major focus on cancer through the development of the FA Cancer Consortium....

Read More >

Research Report Spring/Summer 2022: Six Grants Conclude as Five are Funded

New grants: Cancer Consortium The Fanconi Anemia Cancer Consortium (FACC) is a collaborative partnership between the FA community and a network of clinicians and physician scientists who have expertise in the diagnosis and management of FA cancers and FA cancer research....

Read More >

FARF Launches Cancer Consortium

Why cancer? When the Fanconi Anemia Research Fund (FARF) was founded in 1989, Fanconi anemia (FA) was thought to be a childhood blood disease that led to leukemia. Thanks to years of donor-funded research, we now know that faulty DNA...

Read More >

Research Report Winter 2022: Four New Grants Funded

In early 2022, four new grants were awarded to advance research in cancer preclinical models, Fanconi Anemia Neurological Syndrome (FANS), and mental health. If you’d like to submit a research grant proposal, please contact Isis Sroka, Scientific Director. If you’d like...

Read More >

Stand Up To Cancer Announces New Research Team Focused on FA and HPV-related Head and Neck Cancers

LOS ANGELES – [October 28, 2021] – Stand Up To Cancer (SU2C) today announced the Stand Up To Cancer–Fanconi Anemia Research Fund–Farrah Fawcett Foundation Head and Neck Cancer Research Team. The team will concentrate on new approaches to address head and neck squamous cell carcinoma,...

Read More >